The clinical trials the standard of care for the drug metformin was based on were largely made up of white participants but researchers found that blacks, who are more vulnerable to Type 2 diabetes, respond better to the medication than whites.
The clinical trials the standard of care for the drug metformin was based on were largely made up of white participants but researchers found that blacks, who are more vulnerable to Type 2 diabetes, respond better to the medication than whites.
Share this Article
Recommended